DaciHep (daclatasvir) is a drug used in antiviral therapy for chronic hepatitis C virus. It is most effective in combination with Sofosbuvir for patients with hepatitis C virus of any genotype.
Pharmacological action
DaciHep (daclatasvir) stops the reproduction of the hepatitis virus and reduces the viral load, thus blocking the resumption of the virus in the body.
Method of administration and dosage
The recommended dosage of DaciHep is one tablet of the drug once a day during meals, every day at the same time.
It is recommended to take the drug together with the drug sofosbuvir Sovihep for 3 months.
It is strongly recommended to take the drug under strict medical supervision.
Side effects
The most common side effects:
• fatigue;
• headache;
• nausea;
• insomnia;
• anemia.
Tell your doctor if you have any side effects that bother you.
Contraindications
Do not use DaciHep if you are pregnant or breastfeeding.
Daclatasvir may cause birth defects, fetal harm, or early termination of pregnancy. It is recommended to use forms of contraception to prevent pregnancy while taking this medicine and for 6 months after finishing treatment.
Storage method
Store at a temperature of 15 ° C to 30 ° C in a dry place. Keep out of reach of children.
Our commitments
We deliver medicines to people with hepatitis C at low and competitive prices. We guarantee you the best quality of services.
